News tagged with liver cancer
Metabolic profiles essential for personalizing cancer therapy
One way to tackle a tumor is to take aim at the metabolic reactions that fuel their growth. But a report in the February Cell Metabolism shows that one metabolism-targeted cancer therapy will not fit all. That means that m ...
Feb 07, 2012 |
4 / 5 (1) |
0
Three 'targeted' cancer drugs raise risk of fatal side effects
Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that ...
Feb 06, 2012 |
5 / 5 (1) |
0
|
Lifestyle changes can help prevent 30% of cancers: WHO
More than 30 percent of cancers can be prevented by lifestyle changes, the World Health Organization said Friday, on the eve of World Cancer Day.
Feb 03, 2012 |
5 / 5 (2) |
0
New research confirms need for lung cancer testing
Different kinds of lung cancer behave in different ways, suggesting they are fundamentally different diseases. According to a University of Colorado Cancer Center study published in Cancer, the official journal of the Am ...
Feb 02, 2012 |
4.5 / 5 (2) |
0
|
Plant food supplements in the spotlight
Natural food does not always mean safe food. EU-funded researchers have discovered that the compounds found in some botanicals and botanical preparations, such as plant food supplements, may be detrimental ...
Feb 02, 2012 |
5 / 5 (2) |
0
Researchers indentify a cell-permeable peptide that inhibits hepatitis C
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis.
Jan 31, 2012 |
not rated yet |
0
|
Gender differences in liver cancer risk explained by small changes in genome
Men are four times more likely to develop liver cancer compared to women, a difference attributed to the sex hormones androgen and estrogen. Although this gender difference has been known for a long time, ...
Jan 19, 2012 |
not rated yet |
0
Combination of oral drugs suppresses common type of hepatitis C
A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.
Jan 19, 2012 |
not rated yet |
0
|
Novel gene mutations associated with bile duct cancer
Investigators at the Massachusetts General Hospital (MGH) Cancer Center have identified a new genetic signature associated with bile duct cancer, a usually deadly tumor for which effective treatment currently is limited. ...
Jan 18, 2012 |
not rated yet |
0
|
New method pinpoints important gene-regulation proteins
A novel technique has been developed and demonstrated at Penn State University to map the proteins that read and regulate chromosomes -- the string-like structures inside cells that carry genes. The specific ...
Jan 18, 2012 |
5 / 5 (3) |
0
|
New fibrosis classification improves accuracy of diagnosis in hepatitis C
A new classification for diagnosing fibrosis in patients with chronic hepatitis C virus (HCV) has shown to be as accurate as currently used algorithms, but required no further liver biopsy. The study appearing in the January ...
Jan 10, 2012 |
not rated yet |
0
Studies identify risk factors in rising trend of liver cancer
Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent Mayo Clinic studies published in the January issue of Mayo Clinic Pr ...
Jan 03, 2012 |
4 / 5 (1) |
0
Anti-sense might make sense for treating liver cancer
A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer. The findings might offer a new therapy for this malignancy, which kills an estimated 549,000 people ...
Jan 03, 2012 |
not rated yet |
0
Toxin found in Chinese milk
China has discovered excessive levels of a cancer-causing toxin in milk produced by one of the nation's leading dairy companies, the firm said, in the latest in a series of food safety alarms.
Dec 26, 2011 |
5 / 5 (1) |
1
Previously unconnected molecular networks conspire to promote cancer
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson ...
Dec 22, 2011 |
not rated yet |
0
Liver cancer
Liver cancer is a cancer that starts in the liver. For a thorough understanding of liver cancer it is important to know a brief summary of how the liver works and functions. The liver is the largest organ in the body. It is located below the right lung and under the ribcage. The liver is divided into two lobes: the right lobe and left lobe. Protein is obtained by the liver from a set of sources. The portal vein carries nutrient rich blood from the intestines to the liver and the hepatic artery supplies the liver with blood that is rich in oxygen. Multiple types of tumors can develop in the liver because the liver is made up of many various cells. Tumors that are cancerous are termed malignant and tumors that do not contain cancer are termed benign. Liver cancer is characterized by the presence of malignant hepatic tumors -- tumors or growths on or in the liver (medical terms pertaining to the liver often start in hepato- or hepatic from the Greek word for liver, hēpar, stem hēpat-). They may be discovered on medical imaging (even for a different reason than the cancer itself), or may be present in patients as an abdominal mass, abdominal pain, jaundice, or some other liver dysfunction.
For more information about Liver cancer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
